However, in light of the serious side effects reported after intracerebroventricular infusion of GDNF in parkinsonian patients [71], attention was drown toward MANF and CDNF, which will hopefully make good candidates for novel therapies in PD. The gene discussed is MANF; the disease is Parkinson disease.